Literature DB >> 19088932

Ten-year experience in the management of gallbladder cancer from a single hepatobiliary and pancreatic centre with review of the literature.

Seok L Ong1, Giuseppe Garcea, Sarah C Thomasset, Christopher P Neal, David M Lloyd, David P Berry, Ashley R Dennison.   

Abstract

BACKGROUND: There is no consensus regarding the optimum surgical approach to gallbladder cancer. This study reviews the management of gallbladder cancer in a single unit.
METHODS: Retrospective study of 73 consecutive patients diagnosed with gallbladder cancer. Twenty-three patients underwent surgery with curative intent (surgical group), 28 patients underwent exploratory surgery but had inoperable disease (surgically inoperable group) and 22 patients had inoperable disease radiologically (radiologically inoperable group). Within the surgical group, nine patients (cholecystectomy group) were diagnosed with gallbladder cancer after routine cholecystectomy.
RESULTS: The inoperable groups had significantly higher bilirubin and alkaline phosphatase (ALP) than the surgical group (p=0.02 and p<0.01, respectively). Age>68, white cell count (WCC)>7.6 x 109/L, platelet>345 x 109/L, bilirubin>16 mol/L, ALP >124 iu/L and sodium < or = 137 mmol/L were markers of inoperability. Age, haemoglobin and neutrophil:lymphocyte ratio (NLR) were predictors for survival following surgery (p=0.04, p=0.01 and p<0.01, respectively). The surgical and cholecystectomy groups had significantly higher median survivals than the surgically and radiologically inoperable groups (18.97 and 26.17 months versus 5.03 and 12.20 months, p=0.04).
CONCLUSION: Curative surgical resection of gallbladder cancer improved survival. Exploratory laparotomy which revealed inoperable disease reduced survival. Preoperative WCC, platelet, bilirubin and ALP may be used as additional discriminators during the investigation and work up prior to surgery.

Entities:  

Keywords:  cancer; gallbladder; malignancy; survival

Year:  2008        PMID: 19088932      PMCID: PMC2597309          DOI: 10.1080/13651820802392346

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  36 in total

1.  Surgical treatment of pT2 gallbladder carcinoma: a reevaluation of the therapeutic effect of hepatectomy and extrahepatic bile duct resection based on the long-term outcome.

Authors:  Hiroshi Yokomizo; Takaaki Yamane; Toshihiko Hirata; Michio Hifumi; Tetsu Kawaguchi; Seiji Fukuda
Journal:  Ann Surg Oncol       Date:  2007-01-27       Impact factor: 5.344

2.  Incidence pattern and survival for gallbladder cancer over three decades--an analysis of 10301 patients.

Authors:  R P Kiran; N Pokala; S J Dudrick
Journal:  Ann Surg Oncol       Date:  2006-11-16       Impact factor: 5.344

3.  Clinical significance of extrahepatic bile duct resection for advanced gallbladder cancer.

Authors:  Yoshihiro Sakamoto; Tomoo Kosuge; Kazuaki Shimada; Tsuyoshi Sano; Taizo Hibi; Junji Yamamoto; Tadatoshi Takayama; Masatoshi Makuuchi
Journal:  J Surg Oncol       Date:  2006-09-15       Impact factor: 3.454

4.  Trends in incidence and management of gallbladder carcinoma: a population-based study in France.

Authors:  S Manfredi; A M Benhamiche; N Isambert; P Prost; J L Jouve; J Faivre
Journal:  Cancer       Date:  2000-08-15       Impact factor: 6.860

5.  Post-operative neutrophil-lymphocyte ratio predicts complications following colorectal surgery.

Authors:  Emily J Cook; Stewart R Walsh; Naheed Farooq; Justin C Alberts; Timothy A Justin; Neil J Keeling
Journal:  Int J Surg       Date:  2006-06-27       Impact factor: 6.071

Review 6.  Long-term results after resection for gallbladder cancer. Implications for staging and management.

Authors:  D L Bartlett; Y Fong; J G Fortner; M F Brennan; L H Blumgart
Journal:  Ann Surg       Date:  1996-11       Impact factor: 12.969

7.  Factors influencing postoperative hospital mortality and long-term survival after radical resection for stage IV gallbladder carcinoma.

Authors:  Satoshi Kondo; Yuji Nimura; Junichi Kamiya; Masato Nagino; Michio Kanai; Katsuhiko Uesaka; Norihiro Yuasa; Tsuyoshi Sano; Naokazu Hayakawa
Journal:  World J Surg       Date:  2003-02-27       Impact factor: 3.352

8.  Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer.

Authors:  William G Hawkins; Ronald P DeMatteo; William R Jarnagin; Leah Ben-Porat; Leslie H Blumgart; Yuman Fong
Journal:  Ann Surg Oncol       Date:  2004-03       Impact factor: 5.344

9.  A curative resection improves the postoperative survival rate even in patients with advanced gallbladder carcinoma.

Authors:  Masahiro Kai; Kazuo Chijiiwa; Jiro Ohuchida; Motoaki Nagano; Masahide Hiyoshi; Kazuhiro Kondo
Journal:  J Gastrointest Surg       Date:  2007-08       Impact factor: 3.452

10.  Perineural invasion has a negative impact on survival of patients with gallbladder carcinoma.

Authors:  R Yamaguchi; M Nagino; K Oda; J Kamiya; K Uesaka; Y Nimura
Journal:  Br J Surg       Date:  2002-09       Impact factor: 6.939

View more
  12 in total

1.  Relevance of residual disease after liver resection for incidental gallbladder cancer.

Authors:  Javier C Lendoire; Luis Gil; Fernando Duek; Carlos Quarin; Verónica Garay; Gabriel Raffin; Marcelo Rivaldi; Oks Alejandra; Oscar Imventarza
Journal:  HPB (Oxford)       Date:  2012-06-08       Impact factor: 3.647

2.  Implications of the index cholecystectomy and timing of referral for radical resection of advanced incidental gallbladder cancer.

Authors:  T Tsirlis; F Ausania; S A White; J J French; B C Jaques; R M Charnley; D M Manas
Journal:  Ann R Coll Surg Engl       Date:  2015-03       Impact factor: 1.891

3.  Safety and Efficacy of Low-Dose Single-Agent Capecitabine in Inoperable Gallbladder Cancer with Jaundice Post-Single-System Single-Catheter External Biliary Drainage: a Pilot Study from a Highly Endemic Area.

Authors:  Ravi Gupta; Akshay Anand; Manoj Kumar; Mlb Bhatt; Sudhir Singh; Abhinav Arun Sonkar
Journal:  Indian J Surg Oncol       Date:  2018-07-31

4.  Platelet to lymphocyte ratio as a novel prognostic tool for gallbladder carcinoma.

Authors:  Qing Pang; Ling-Qiang Zhang; Rui-Tao Wang; Jian-Bin Bi; Jing-Yao Zhang; Kai Qu; Su-Shun Liu; Si-Dong Song; Xin-Sen Xu; Zhi-Xin Wang; Chang Liu
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

5.  Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer.

Authors:  Viren Asher; Joanne Lee; Anni Innamaa; Anish Bali
Journal:  Clin Transl Oncol       Date:  2011-07       Impact factor: 3.405

6.  Incidental gallbladder cancer diagnosis confers survival advantage irrespective of tumour stage and characteristics.

Authors:  Moath Alarabiyat; Syed Soulat Raza; John Isaac; Darius Mirza; Ravi Marudanayagam; Keith Roberts; Manuel Abradelo; David C Bartlett; Bobby V Dasari; Robert P Sutcliffe; Nikolaos A Chatzizacharias
Journal:  World J Gastroenterol       Date:  2022-05-14       Impact factor: 5.374

7.  Incidental pT2-T3 gallbladder cancer after a cholecystectomy: outcome of staging at 3 months prior to a radical resection.

Authors:  Fabio Ausania; Theodoris Tsirlis; Steven A White; Jeremy J French; Bryon C Jaques; Richard M Charnley; Derek M Manas
Journal:  HPB (Oxford)       Date:  2013-01-07       Impact factor: 3.647

8.  Incidental gallbladder cancer diagnosed following laparoscopic cholecystectomy.

Authors:  Sae Byeol Choi; Hyung Joon Han; Chung Yun Kim; Wan Bae Kim; Tae-Jin Song; Sung Ock Suh; Young Chul Kim; Sang Yong Choi
Journal:  World J Surg       Date:  2009-12       Impact factor: 3.352

9.  Prognostic significance of preoperative platelet count in patients with gallbladder cancer.

Authors:  Rui-Tao Wang; Ling-Qiang Zhang; Yi-Ping Mu; Jian-Bo Li; Xin-Sen Xu; Qing Pang; Lian-Kang Sun; Xing Zhang; Shun-Bin Dong; Lin Wang; Chang Liu
Journal:  World J Gastroenterol       Date:  2015-05-07       Impact factor: 5.742

10.  Surgical strategy for suspected early gallbladder carcinoma including incidental gallbladder carcinoma diagnosed during or after cholecystectomy.

Authors:  Toshikatsu Nitta; Jun Kataoka; Masato Ohta; Kensuke Fujii; Yuko Takashima; Yoshihiro Inoue; Takashi Ishibashi
Journal:  Ann Med Surg (Lond)       Date:  2018-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.